Literature DB >> 32885549

Relationship between the metabolic and lipid profile in follicular fluid of women undergoing in vitro fertilization.

Simone Luti1, Tania Fiaschi1, Francesca Magherini1, Pietro A Modesti2, Paola Piomboni3, Laura Governini3, Alice Luddi3, Angela Amoresano4, Anna Illiano4, Gabriella Pinto4, Alessandra Modesti1, Tania Gamberi1.   

Abstract

Among the follicular fluid (FF) components promoting the development of the oocyte are included glycoproteins, several fatty acids, and steroid hormones synthesized by the dominant follicle. For this, the analysis of the metabolites present in FF can determine the quality of the oocyte. FF composition is in part determined by local follicular metabolic processes and in part a plasma transudate. Since the causes of impaired fertility may be due to a metabolic imbalance, metabolomics is useful to identify low molecular weight metabolites. Oxidative stress is involved in human infertility and the use of metabolomics can be crucial to identify which other metabolites besides reactive oxygen species are involved in oxidative stress correlated to infertility. To obtain new information on the study of signaling molecules in FF, the knowledge of the lipid content will be important to improve information on the understanding of follicular development. The objective of this study is to identify (a) a metabolic profile and a lipid profile of FF in women undergoing in vitro fertilization and (b) to correlate the previous information obtained regarding adiponectin and oxidative stress with the metabolic and lipid profile obtained in the present study. As result, we found an increase in oxidative stress due to both an increase of androgens and an accumulation of lipids in the follicular environment and we suggest that this might be one of the causes of reduced fertility.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  follicular microenvironment; lipidic profile; metabolic profile; network pathways

Mesh:

Substances:

Year:  2020        PMID: 32885549     DOI: 10.1002/mrd.23415

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  6 in total

1.  Glutamine and norepinephrine in follicular fluid synergistically enhance the antioxidant capacity of human granulosa cells and the outcome of IVF-ET.

Authors:  Lulu Wang; Chengliang Zhou; Junyan Sun; Qiuwan Zhang; Dongmei Lai
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

Review 2.  Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.

Authors:  Ana Teresa Brinca; Ana Cristina Ramalhinho; Ângela Sousa; António Hélio Oliani; Luiza Breitenfeld; Luís A Passarinha; Eugenia Gallardo
Journal:  Biomedicines       Date:  2022-05-27

3.  Relationships between Sex and Adaptation to Physical Exercise in Young Athletes: A Pilot Study.

Authors:  Gabriella Pinto; Rosamaria Militello; Angela Amoresano; Pietro Amedeo Modesti; Alessandra Modesti; Simone Luti
Journal:  Healthcare (Basel)       Date:  2022-02-11

4.  Metabolic signatures in human follicular fluid identify lysophosphatidylcholine as a predictor of follicular development.

Authors:  Jihong Yang; Yangbai Li; Suying Li; Yan Zhang; Ruizhi Feng; Rui Huang; Minjian Chen; Yun Qian
Journal:  Commun Biol       Date:  2022-07-29

5.  Human amnion-derived mesenchymal stem cells improved the reproductive function of age-related diminished ovarian reserve in mice through Ampk/FoxO3a signaling pathway.

Authors:  Hanwen Liu; Chunyan Jiang; Boya La; Meng Cao; Song Ning; Jing Zhou; Zhengjie Yan; Chuyu Li; Yugui Cui; Xiang Ma; Meilian Wang; Li Chen; Youjia Yu; Feng Chen; Yuexin Zhang; Huimin Wu; Jiayin Liu; Lianju Qin
Journal:  Stem Cell Res Ther       Date:  2021-06-02       Impact factor: 6.832

6.  Redox Homeostasis and Metabolic Profile in Young Female Basketball Players during in-Season Training.

Authors:  Rosamaria Militello; Simone Luti; Matteo Parri; Riccardo Marzocchini; Riccardo Soldaini; Alessandra Modesti; Pietro Amedeo Modesti
Journal:  Healthcare (Basel)       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.